| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $27.9M | -3.8% |
| SG&A Expense | $10.9M | -11.5% |
| Operating Income | -$38.8M | +6.4% |
| Pre-tax Income | -$38.1M | +11.3% |
| Net Income | -$38.1M | +11.3% |
| EPS (Basic) | -$0.25 | +21.9% |
| EPS (Diluted) | -$0.25 | +21.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.1M | +53.2% |
| Short-term Investments | $73.8M | -42.0% |
| Current Assets | $129.0M | -21.8% |
| Total Assets | $139.8M | -20.9% |
| Current Liabilities | $5.9M | -60.0% |
| Long-term Debt | $26.1M | +1.6% |
| Total Liabilities | $32.0M | -0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.6M | +13.8% |
| Capital Expenditures | $9K | -84.2% |
| Investing Cash Flow | $52.6M | +175.8% |
| Financing Cash Flow | $87K | -99.9% |
| Free Cash Flow | -$34.6M | +13.9% |
| Stockholders' Equity |
| $107.8M |
| -25.4% |